ciglitazone has been researched along with Infections, Staphylococcal in 1 studies
ciglitazone: structure given in second source; PPAR agonist used for type II diabetes
ciglitazone : An aromatic ether that consists of 1,3-thiazolidine-2,4-dione with position 5 substituted by a 4-[(1-methylcyclohexyl)methoxy]benzyl group. A selective PPARgamma agonist.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kielian, T | 1 |
| Syed, MM | 1 |
| Liu, S | 1 |
| Phulwani, NK | 1 |
| Phillips, N | 1 |
| Wagoner, G | 1 |
| Drew, PD | 1 |
| Esen, N | 1 |
1 other study available for ciglitazone and Infections, Staphylococcal
| Article | Year |
|---|---|
The synthetic peroxisome proliferator-activated receptor-gamma agonist ciglitazone attenuates neuroinflammation and accelerates encapsulation in bacterial brain abscesses.
Topics: Animals; Brain Abscess; Cell Wall; Fibronectins; Inflammation; Ligands; Macrophages; Mice; Mice, Inb | 2008 |